ANGO - AngioDynamics, Inc.
NEXT EARNINGS:
Apr 1, 2026
EPS Est: $-0.11
|
Rev Est: $76.8M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$18.00
DETAILS
HIGH:
$18.00
LOW:
$18.00
MEDIAN:
$18.00
CONSENSUS:
$18.00
UPSIDE:
57.48%
Market Cap:
471.11M
Volume:
562,939
Avg Volume:
593,552
52 Week Range:
8.27-13.99
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
0.50
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
748
IPO Date:
2004-06-01
EPS (TTM):
-0.83
P/E Ratio:
-12.30
Revenue (TTM):
292.50M
Total Assets:
280.14M
Total Debt:
N/A
Cash & Equiv:
55.89M
Rev Growth (5Y):
2.1%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-11.8%
Debt/Equity:
N/A
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-06 | $-0.15 | $-0.10 | -53.4% | $79.4M | $76.2M | +4.3% |
| 2025-10-02 | $-0.10 | $-0.14 | +28.6% | $75.7M | $76.3M | -0.8% |
| 2025-07-15 | $-0.03 | $-0.13 | +76.9% | $80.2M | $74.3M | +7.9% |
| 2025-04-02 | $0.03 | $-0.13 | +123.1% | $72.0M | $74.3M | -3.0% |
| 2025-01-08 | $-0.04 | $-0.11 | +63.6% | $72.8M | $70.6M | +3.2% |
| 2024-10-03 | $-0.11 | $-0.15 | +26.7% | $67.5M | $67.9M | -0.6% |
| 2024-07-16 | $-0.06 | $-0.20 | +70.0% | $71.0M | $70.8M | +0.2% |
| 2024-04-04 | $-0.16 | $-0.14 | -14.3% | $75.2M | $75.7M | -0.7% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 292.50M | 303.91M | 338.75M | 316.22M | 291.01M | 264.16M | 359.48M | 344.29M | 349.64M | 353.69M | 356.97M | 354.45M |
| Net Income | (33.99M) | (184.35M) | (52.44M) | (26.55M) | (31.55M) | (166.79M) | 61.34M | 16.34M | (7.05M) | (43.59M) | (3.39M) | 2.35M |
| EPS | -0.83 | -4.59 | -1.33 | -0.68 | -0.82 | -4.37 | 1.64 | 0.44 | 0.19 | -1.23 | -0.09 | 0.09 |
| Total Assets | 280.14M | 317.67M | 532.64M | 552.75M | 561.44M | 595.51M | 836.44M | 705.47M | 707.96M | 728.06M | 773.62M | 800.16M |
| Total Debt | 0 | 4.73M | 64.58M | 33.78M | 20.00M | 40.84M | 136.54M | 93.72M | 105.94M | 133.46M | 147.63M | 153.58M |
| Cash & Equivalents | 55.89M | 76.06M | 44.62M | 28.82M | 48.16M | 54.44M | 227.64M | 74.10M | 47.54M | 32.33M | 18.39M | 16.11M |
| Operating Cash Flow | (10.13M) | (28.16M) | 78,000 | (7.19M) | 24.09M | (14.55M) | 37.44M | 41.29M | 55.74M | 45.22M | 25.68M | 24.68M |
| Free Cash Flow | (14.59M) | (33.93M) | (4.27M) | (11.49M) | 18.91M | (22.14M) | 34.32M | 37.63M | 52.74M | 39.62M | 12.95M | 12.07M |
| FCF per Share | -0.36 | -0.84 | -0.11 | -0.29 | 0.49 | -0.58 | 0.92 | 1.01 | 1.44 | 1.10 | 0.36 | 0.34 |
| Book Value | 182.97M | 205.59M | 378.30M | 424.49M | 439.46M | 455.87M | 614.82M | 542.60M | 517.03M | 507.03M | 545.02M | 537.89M |
| Cash & ST Investments | 55.89M | 76.06M | 44.62M | 28.82M | 48.16M | 54.44M | 227.64M | 75.41M | 48.76M | 33.99M | 20.08M | 17.91M |
| ROC Equity | -0.19 | -0.90 | -0.14 | -0.06 | -0.07 | -0.37 | 0.10 | 0.03 | -0.01 | -0.09 | -0.01 | 0.00 |